Cargando…
Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
Patients with severe mental illness have increased mortality, often linked to cardio-metabolic disease. Non-alcoholic fatty liver disease (NAFLD) incidence is higher in patients with schizophrenia and is exacerbated with antipsychotic treatment. NAFLD is associated with obesity and insulin resistanc...
Autores principales: | Rostama, Bahman, Beauchemin, Megan, Bouchard, Celeste, Bernier, Elizabeth, Vary, Calvin P. H., May, Meghan, Houseknecht, Karen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763698/ https://www.ncbi.nlm.nih.gov/pubmed/33302598 http://dx.doi.org/10.3390/ijms21249362 |
Ejemplares similares
-
The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
por: May, Meghan, et al.
Publicado: (2019) -
Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk
por: May, Meghan, et al.
Publicado: (2020) -
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
por: Gangopadhyay, Anwesha, et al.
Publicado: (2022) -
Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic Approach
por: May, Meghan, et al.
Publicado: (2022) -
Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2007)